Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jasjit K, Multani"'
Autor:
Ani C. Khodavirdi, Jasjit K. Multani, Sam S. Oh, Fiston Vuvu, Mark E. Bensink, Karen M. Stockl, Kevin Hawkins, Chia-Chun Chiang, A. Laine Green, Stewart J. Tepper
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
IntroductionMigraine is a debilitating neurological disorder, with a wide range of symptoms and disease burden, underscoring the heterogeneity of patients’ disease characteristics and treatment needs. To characterize the profile of migraine patient
Externí odkaz:
https://doaj.org/article/40ba0f75cd51477882b9369731b68aae
Autor:
Alexander Slowley, Kelesitse Phiri, Jasjit K. Multani, Vicky Casey, Sheila Mpima, Marie Yasuda, Chi‐Chang Chen, Fil Manuguid, Jessica Chao, Amine Aziez, Kelly F. Bell, Alexander Stojadinovic
Publikováno v:
Thoracic Cancer, Vol 14, Iss 28, Pp 2846-2858 (2023)
Abstract Background Real‐world evidence is increasingly used to guide treatment and regulatory decisions for non‐small cell lung cancer (NSCLC). Real‐world treatment patterns and clinical outcomes among patients with advanced/metastatic NSCLC i
Externí odkaz:
https://doaj.org/article/2bafcf605a8c49ab901542b701ab65ea
Autor:
Julie Settles, Hong Kan, Christopher J. Child, Magdaliz Gorritz, Jasjit K. Multani, Catherine B. McGuiness, Rolin L. Wade, Brian M. Frier
Publikováno v:
Diabetes, Obesity and Metabolism. 24:1235-1244
Several risk factors for severe hypoglycaemia (SH) are associated with insulin-treated diabetes. This study explored potential risk factors in adults with insulin-treated type 2 diabetes mellitus (T2DM).In this case-control study, adults with T2DM in
Autor:
Mousam Parekh, Joanna Campbell, Vanessa Shih, Mildred M.G. Olivier, Jasjit K. Multani, Eydie Miller-Ellis, Catherine B McGuiness, Chi-Chang Chen
Publikováno v:
Ophthalmology Glaucoma. 4:490-503
PURPOSE To provide updated estimates of the clinical and economic burden in patients with ocular hypertension (OHT) or open-angle glaucoma (OAG) by disease severity in the United States and to estimate incremental costs associated with disease progre
Autor:
Katelyn R Keyloun, Catherine B McGuiness, Bijal Shah-Manek, Arghavan Almony, Chi-Chang Chen, Jasjit K. Multani, Joanna Campbell
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 27:1260-1272
BACKGROUND: New treatment alternatives have revolutionized the management of nAMD. However, there is limited evidence on the clinical and economic burden of nAMD in commercially insured US patients...
Autor:
Julie Settles, Christopher J. Child, Magdaliz Gorritz, Jasjit K. Multani, Catherine B. McGuiness, Rolin L. Wade, Hong Kan, Alexander Stöckl
Publikováno v:
Hand in Hand zum Ziel – einfach.besser.messbar www.diabeteskongress.de.
Autor:
null Julie Settles, null Hong Kan, null Christopher J. Child, null Magdaliz Gorritz, null Jasjit K. Multani, null Catherine B. McGuiness, null Rolin L. Wade, null Brian M. Frier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::525b9cef09888dd4d2d53456bd794e75
https://doi.org/10.1111/dom.14690/v3/response1
https://doi.org/10.1111/dom.14690/v3/response1
Autor:
Hong Kan, Magdaliz Gorritz, Jasjit K. Multani, Rolin L Wade, Christopher J. Child, Catherine B McGuiness, Julie Settles
Publikováno v:
Diabetes. 70
Background: In insulin-treated patients (pts) with T2DM, untreated severe hypoglycemia (SH) can be life-threatening. We used a healthcare claims database (db) to identify less established SH risk factors in this group. Methods: Adults with T2DM and
Publikováno v:
HeadacheREFERENCES. 61(4)
OBJECTIVE To describe patient characteristics, adherence, and treatment patterns, among adult migraine patients in the United States prescribed erenumab. BACKGROUND Migraine is a highly prevalent and debilitating disease characterized by recurrent at
Autor:
Vanessa, Shih, Mousam, Parekh, Jasjit K, Multani, Catherine B, McGuiness, Chi-Chang, Chen, Joanna H, Campbell, Eydie, Miller-Ellis, Mildred M G, Olivier
Publikováno v:
Ophthalmology. Glaucoma. 4(5)
To provide updated estimates of the clinical and economic burden in patients with ocular hypertension (OHT) or open-angle glaucoma (OAG) by disease severity in the United States and to estimate incremental costs associated with disease progression.Re